We recently received a small grant from the Progeria Research Foundation to study Progeria (Hutchinson-Gilford Progeria Syndrome), which is a devastating inherited disease. The disease is genetic in that it is caused by a mutation(s) that was identified in the early 1990s by the [now] director of the NIH. However, there is hope that certain drugs and phytochemicals like sulforaphane may prolong life and enhance quality of life in the children who are stricken with this very rare condition. Furthermore, better understanding this disease may enhance our understanding of healthy aging.
Read more on the Progeria Research Foundation, and on our grant.
Dr. Fahey’s is a nutritional biochemist with a passion for the potential of phytochemistry to reduce the burden of chronic disease and to enhance and prolong healthspan. He runs the Cullman Chemoprotection Center.
Latest posts by Dr. Jed Fahey (see all)
- Lewis B. Cullman, Generous Patron and Friend, Dies at 100 - June 20, 2019
- Chemoprotection News - March 4, 2019
- Will Progeria respond to phytochemicals like sulforaphane? - March 1, 2016